Information zum Seitenaufbau und Sprungmarken fuer Screenreader-Benutzer: Ganz oben links auf jeder Seite befindet sich das Logo der JLU, verlinkt mit der Startseite. Neben dem Logo schliesst sich die Hauptnavigation in Form der Reiternavigation an. Es folgt die Grobnavigation links unterhalb des Logos. Die Feinnavigation findet sich in der linken Spalte. Unterhalb der Reiternavigation ist die Brotkrumen-Navigation. In der Mitte der Seite befindet sich der Inhaltsbereich. In der rechten Spalte finden Sie die Suche und ueblicherweise Kontaktdaten und direkte Links. Als Abschluss der Seite sind im Fussbereich Links zu Barrierefreiheit, Kontakt Web-Master, Impressum, Plone-Kurse, Hilfe, Login fuer Redakteure aufgelistet.

vor "Barrierefreiheit" im Seitenfuss vor Reiternavigation vor Grobnavigation in linker Kolumne vor Feinnavigation in linker Kolumne vor Sie sind hier vor Inhalt vor rechter Kolumne mit zusaetzlichen Informationen im Suchfeld Suche nach vor Redaktion vor Kontakt Web-Master im Seitenfuss vor Impressum im Seitenfuss

Reiternavigation
You are here: Home Research Research Organizations Special Research Areas SFB/Transregio 81 - Chromatin Changes in Differentiation and Malignancy
Document Actions

SFB/Transregio 81 - Chromatin Changes in Differentiation and Malignancy

Special Research Area/Transregional 81: Chromatin Changes in Differentiation and Malignancy

Duration: 2010 - 2014

Spokesman:
Prof. Dr. Rainer Renkawitz
Institute for Genetics
Heinrich-Buff-Ring 58
35392 Gießen

 

Short Description

In June 2010 at the universities of Giessen, Marburg, and Rotterdam, as well as at the Max Planck Institute for Heart and Lung Research in Bad Nauheim, the international SFB/TRR 81 "Chromatin Changes in Differentiation and Malignancy" was established. The JLU is spearheading the research; spokesman is Prof. Dr. Rainer Renkawitz (Institute for Genetics at the JLU).  The research network deals with the role of chromatin in the regulation of genetic activity.  In the case of a pathological change, genes incorrectly turning on or off can have an influence on the development of tumors or other diseases.

Humans and other higher organisms possess a multitude of various cell types with large differences in their appearance and function.  Although the cells of an organism largely have identical genes, a heart muscle cell, for example, uses different genes than those of a blood cell.  Thus the activity pattern of a muscle precursor cell's genes must be transferred and modified onto further (muscle) daughter cells.  Since necessary genes in varying groups in the genome are present simultaneously, there are numerous inactive genes scattered between groups of active genes.

Inactivity is frequently transmitted via changes in the DNA (DNA methylation) and chemical modification of the DNA-packing histone (chromatin).  These modifications are the cause of epigenetics, the passing on of the activity condition onto daughter cells, and this is what the SFB/TRR 81 is examining.

At the JLU, not only is the Institute for Genetics (Faculty 08 - Biology and Chemistry) participating but also the Biochemical Institute and the Rudolf Bucheim Institute for Pharmacology (both Faculty 11 - Medicine).  By establishing this SFB with the participation of German and Dutch workgroups, research at an international level will be possible in order to answer very current questions of epigenetics.  Furthermore, the possibility of international exchanges, an important experience for future career possibilities, is available for doctoral students during their education.

Font size: large | standard | small
Redaktion
25.04.2013 15:37
 

| Barrierefreiheit | Kontakt Web-Master | Impressum | Plone-Kurse | Hilfe | Login für Redakteure
Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: